Legal & General Group Plc - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 3 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 8.4%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2022$2,000
-75.0%
3,2640.0%0.00%
Q1 2022$8,000
-50.0%
3,2640.0%0.00%
Q4 2021$16,000
-38.5%
3,2640.0%0.00%
Q3 2021$26,000
+13.0%
3,2640.0%0.00%
Q2 2021$23,000
-39.5%
3,264
-31.6%
0.00%
Q1 2021$38,0000.0%4,773
-2.1%
0.00%
Q4 2020$38,000
+8.6%
4,8770.0%0.00%
Q3 2020$35,000
-43.5%
4,877
-26.9%
0.00%
Q2 2020$62,000
+264.7%
6,670
+86.0%
0.00%
Q1 2020$17,000
-54.1%
3,586
-25.2%
0.00%
Q4 2019$37,000
+2.8%
4,797
+2.9%
0.00%
Q3 2019$36,000
+20.0%
4,6610.0%0.00%
Q2 2019$30,000
+11.1%
4,661
+37.5%
0.00%
Q1 2019$27,000
+50.0%
3,391
+39.7%
0.00%
Q4 2018$18,000
-21.7%
2,4280.0%0.00%
Q3 2018$23,000
-11.5%
2,4280.0%0.00%
Q2 2018$26,0002,4280.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 279,678$2,587,00010.00%
Aisling Capital Management LP 1,691,151$15,643,0005.97%
Samsara BioCapital, LLC 967,500$8,949,0002.88%
Bain Capital Life Sciences Investors, LLC 2,700,000$24,975,0002.62%
Soleus Capital Management, L.P. 369,852$3,421,0001.95%
Nantahala Capital Management 3,204,830$29,645,0000.89%
Lion Point Capital, LP 300,000$2,775,0000.67%
Abingworth LLP 240,500$2,221,0000.62%
Sio Capital Management, LLC 211,104$1,953,0000.57%
Orbimed Advisors 4,015,524$37,144,0000.52%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders